BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10788672)

  • 1. Mutational analysis of the synapsin III gene on chromosome 22q12-q13 in schizophrenia.
    Ohtsuki T; Ichiki R; Toru M; Arinami T
    Psychiatry Res; 2000 Apr; 94(1):1-7. PubMed ID: 10788672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synapsin III gene polymorphisms and schizophrenia.
    Ohmori O; Shinkai T; Hori H; Kojima H; Nakamura J
    Neurosci Lett; 2000 Jan; 279(2):125-7. PubMed ID: 10674637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A third member of the synapsin gene family.
    Kao HT; Porton B; Czernik AJ; Feng J; Yiu G; Häring M; Benfenati F; Greengard P
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4667-72. PubMed ID: 9539796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare polymorphism affects a mitogen-activated protein kinase site in synapsin III: possible relationship to schizophrenia.
    Porton B; Ferreira A; DeLisi LE; Kao HT
    Biol Psychiatry; 2004 Jan; 55(2):118-25. PubMed ID: 14732590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Synapsin III gene promoter polymorphisms and multiple sclerosis.
    Liguori M; Cittadella R; Manna I; Valentino P; La Russa A; Serra P; Trojano M; Messina D; Ruscica F; Andreoli V; Romeo N; Livrea P; Quattrone A
    J Neurol; 2004 Feb; 251(2):165-70. PubMed ID: 14991350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage and family-based association study of schizophrenia and the synapsin III locus that maps to chromosome 22q13.
    Stöber G; Meyer J; Nanda I; Wienker TF; Saar K; Knapp M; Jatzke S; Schmid M; Lesch KP; Beckmann H
    Am J Med Genet; 2000 Jun; 96(3):392-7. PubMed ID: 10898920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the promoter and coding regions of the synapsin III gene. A lack of association with schizophrenia.
    Imai K; Harada S; Kawanishi Y; Tachikawa H; Okubo T; Suzuki T
    Neuropsychobiology; 2001; 43(4):237-41. PubMed ID: 11340362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of synapsin III gene in schizophrenia.
    Tsai MT; Hung CC; Tsai CY; Liu MY; Su YC; Chen YH; Hsiao KJ; Chen CH
    Am J Med Genet; 2002 Jan; 114(1):79-83. PubMed ID: 11840510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association and expression study of synapsin III and schizophrenia.
    Chen Q; Che R; Wang X; O'Neill FA; Walsh D; Tang W; Shi Y; He L; Kendler KS; Chen X
    Neurosci Lett; 2009 Nov; 465(3):248-51. PubMed ID: 19766700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive association between synapsin II and schizophrenia.
    Chen Q; He G; Wang XY; Chen QY; Liu XM; Gu ZZ; Liu J; Li KQ; Wang SJ; Zhu SM; Feng GY; He L
    Biol Psychiatry; 2004 Aug; 56(3):177-81. PubMed ID: 15271586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic search for mutations in the human tissue inhibitor of metalloproteinases-3 (TIMP-3) gene on chromosome 22 and association study with schizophrenia.
    Hung CC; Chen YH; Tsai MT; Chen CH
    Am J Med Genet; 2001 Apr; 105(3):275-8. PubMed ID: 11353449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of schizophrenia in African Americans to polymorphism in synapsin III gene.
    Lachman HM; Stopkova P; Rafael MA; Saito T
    Psychiatr Genet; 2005 Jun; 15(2):127-32. PubMed ID: 15900227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs.
    Tan ML; Dyck BA; Gabriele J; Daya RP; Thomas N; Sookram C; Basu D; Ferro MA; Chong VZ; Mishra RK
    Pharmacogenomics J; 2014 Feb; 14(1):63-9. PubMed ID: 23529008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic search for mutations in the 14-3-3 eta chain gene on chromosome 22 in schizophrenics.
    Hayakawa T; Ishiguro H; Toru M; Hamaguchi H; Arinami T
    Psychiatr Genet; 1998; 8(1):33-6. PubMed ID: 9564686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of synapsin III-196 promoter mutation in schizophrenia and bipolar disorder.
    Lachman HM; Stopkova P; Papolos DF; Pedrosa E; Margolis B; Aghalar MR; Saito T
    Neuropsychobiology; 2006; 53(2):57-62. PubMed ID: 16511335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family-based association study of synapsin II and schizophrenia.
    Chen Q; He G; Qin W; Chen QY; Zhao XZ; Duan SW; Liu XM; Feng GY; Xu YF; St Clair D; Li M; Wang JH; Xing YL; Shi JG; He L
    Am J Hum Genet; 2004 Nov; 75(5):873-7. PubMed ID: 15449241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic mutation analysis of the catechol O-methyltransferase gene as a candidate gene for schizophrenia.
    Chen CH; Lee YR; Chung MY; Wei FC; Koong FJ; Shaw CK; Yeh JI; Hsiao KJ
    Am J Psychiatry; 1999 Aug; 156(8):1273-5. PubMed ID: 10450274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of synapsin II (SYN2) genes to human chromosome 3p and mouse chromosome 6 band F.
    Li X; Rosahl TW; Südhof TC; Francke U
    Cytogenet Cell Genet; 1995; 71(3):301-5. PubMed ID: 7587399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Search for mutations in the beta 1 GABAA receptor subunit gene in patients with schizophrenia.
    Coon H; Sobell J; Heston L; Sommer S; Hoff M; Holik J; Umar F; Robertson M; Reimherr F; Wender P
    Am J Med Genet; 1994 Mar; 54(1):12-20. PubMed ID: 8178835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of the neuronal cadherin gene CELSR1 and exclusion as a candidate for catatonic schizophrenia in a large family.
    Gross J; Grimm O; Ortega G; Teuber I; Lesch KP; Meyer J
    Psychiatr Genet; 2001 Dec; 11(4):197-200. PubMed ID: 11807409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.